cardiovascular prevention | versus placebo or control No demonstrated result for efficacy | 1 trial | meta-analysis | | Trial | control | p<0.05 | harm | NS |
---|
CDP tyroxine, 1975 | thyroxine vs placebo | | | |
Trial | Treatments | Patients | Method |
---|
CDP tyroxine, 1975 | thyroxine (n=1083) vs. placebo (n=2715) | | Parallel groups Sample size: 1083/2715 Primary endpoint: FU duration: 3.0 years |
|